H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)

On: April 29, 2026, 9:34 am EDT

URL has been copied successfully!

Share this story:

Previous Post:Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial

Next Post:Opes Wealth Sells Its Entire FIXD Stake -- Is This $9.3 Million Bond ETF Exit A Signal?